» Articles » PMID: 32245567

Prognostic Utility of Monocyte to High-Density Lipoprotein Ratio in Patients With Acute Coronary Syndrome: A Meta-Analysis

Overview
Journal Am J Med Sci
Publisher Elsevier
Specialty General Medicine
Date 2020 Apr 5
PMID 32245567
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The monocyte to high-density lipoprotein ratio (MHR) has been used to predict adverse clinical outcomes in patients with acute coronary syndrome (ACS). This meta-analysis aimed to evaluate the prognostic utility of MHR in patients with ACS.

Materials And Methods: We comprehensively searched for relevant studies in Pubmed, Embase, CNKI, WanFang and VIP databases until March 12, 2019. Epidemiologic studies investigating the association between MHR and major adverse cardiovascular events (MACE) or all-cause mortality in patients with ACS were included. Pooled effect was expressed as risk ratios (RR) with 95% confidence intervals (CI) for the highest versus the reference lower MHR group.

Results: Eight studies involving 6,480 patients with ACS were included and analyzed. Meta-analysis indicated that the highest MHR was significantly associated with higher risk of MACE (RR 1.65; 95%CI 1.36-2.02) and all-cause mortality (RR 2.61; 95%CI 1.29-4.89) after adjusting for the conventional confounders. The prognostic values of MACE with the highest MHR caused no significant changes in the in-hospital follow-up (RR 1.76; 95%CI 1.34-2.32) and >6 months follow-up (RR 1.68; 95%CI 1.08-2.62) subgroups. Furthermore, ST elevation myocardial infarction patients with the highest MHR had a 2.07-fold higher risk of in-hospital MACE (RR 2.07; 95%CI 1.52-2.80).

Conclusions: Elevated MHR is independently associated with an increased risk of MACE and all-cause mortality in patients with ACS. MHR may serve as a potential prognostic indicator for ACS prognosis.

Citing Articles

The monocyte-to-HDL-cholesterol ratio predicts new-onset atrial fibrillation in patients with acute STEMI.

Tanik V, Tunca C, Kalkan K, Kivrak A, Ozlek B Biomark Med. 2025; 19(4):121-128.

PMID: 39878450 PMC: 11834425. DOI: 10.1080/17520363.2025.2459590.


The correlation between serum MHR and NLR and the severity of coronary lesions in NSTE-ACS patients of different genders.

Yang Y, Lv X, Tan K, Li K, Li S, Meng X Front Cardiovasc Med. 2025; 11:1469730.

PMID: 39877025 PMC: 11772418. DOI: 10.3389/fcvm.2024.1469730.


Prognostic Value of the Preoperative Lymphocyte-to-Monocyte Ratio for Postoperative Adverse Events in Patients with Acute Type a Aortic Dissection.

Jia L, Wang Y, Wang J, Lin Y, Wang C, Chen C J Inflamm Res. 2025; 18():519-529.

PMID: 39810977 PMC: 11731014. DOI: 10.2147/JIR.S490339.


Impact of treatment management on the hospital stay in patients with acute coronary syndrome.

Tang X, Gong Y, Chen Y, Zhou Y, Wang Y BMC Cardiovasc Disord. 2024; 24(1):630.

PMID: 39522008 PMC: 11549769. DOI: 10.1186/s12872-024-04304-0.


Relation between peripheral blood inflammatory indices and severity of central retinal artery occlusion.

Hu W, Huang Y, Zhou Q, Huang X PeerJ. 2024; 12:e18129.

PMID: 39364366 PMC: 11448653. DOI: 10.7717/peerj.18129.